Trivarx Ltd has released a press release.
TRI-001 Algorithm and Phase 2 Trial Update
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from TrivarX
- December 2023 Quarterly Activities Report and Appendix 4C
- Phase 2 SAMDE Study Update
- Board and Management Transition
- Letter to Shareholders & Notice of GM & Proxy Form
- Phase 2 Trial Commences for SAMDE Study
Later from TrivarX
- TrivarX Receives $888k R&D Tax Incentive
- Response to ASX Price Query
- Appendix 4D & Half-Year Financial Report to 31 December 2023
- March 2024 Quarterly Activities Report and Appendix 4C
- TrivarX Receives Firm Commitments to Raise $2.5 million
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX